BrioVAD heart pump study for advanced heart failure
Part of Heart & circulation clinical trials.
This trial tests a new heart pump (BrioVAD) for people with very advanced heart failure. It aims to help those who are not getting better with standard treatments or who need extra support like IV medicines or a balloon pump.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your heart pumps blood poorly (ejection fraction less than 30%).
- You have severe shortness of breath even with mild activity (NYHA Class III or IV).
- You are on IV heart medicines or have a cardiac pump (balloon pump) to help your heart.
- You have tried standard heart failure treatments for at least 45 days and they are not working well.
- You are willing to use contraception if you could become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a left ventricular assist system (a mechanical heart pump for the left side of the heart) in people with very severe heart failure. It may help people who are too sick or not improving despite best available medical treatment.
This trial tests a new left-ventricular assist device (LVAD) called BrioVAD for people with advanced heart failure who are not getting enough benefit from medicines. If you qualify, the device is implanted to help your heart pump blood.
This trial tests a new left ventricular assist device (LVAD) for people with advanced heart failure who are not responding to standard treatments and are eligible for a heart transplant. The pump helps the heart circulate blood.
This trial is evaluating a new temporary heart pump called CorVad for people who develop severe right heart failure shortly after heart surgery, a heart attack, or a heart transplant. The pump is designed to help the right side of the heart pump blood when medications are not enough.
This trial is testing a temporary heart pump device that helps your heart pump blood when it's too weak to do its job. It's for people who have severe heart failure (cardiogenic shock) despite getting powerful medications to keep their heart working.
This trial compares an LVAD device (a pump placed in the chest) plus medicines versus medicines alone for people with advanced, end-stage heart failure. It aims to see which approach works better to help patients live and stay out of the hospital.
Hear when a new Cardiovascular Diseases (CVD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.